DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

DAIC

MARCH 28, 2025

This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. 2012) 380:2095128. For more information on Revolution Vibe, please visit gehealthcare.com. Eur J Radiol. 2008;66(1):3741. doi:10.1016/j.ejrad.2007.05.006. 2007.05.006.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Frontiers in Cardiovascular Medicine

DECEMBER 17, 2023

In recent years, the emergence of smartphones and microelectromechanical systems has allowed innovative solutions for conveniently measuring HR, such as smartphone ECG, smartphone photoplethysmography (PPG), and seismocardiography (SCG). The seven selected articles’ sample sizes varied from 11 to 435 participants.

Article 64

Article Heart Rhythm Innovation Technology 64

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Stroke: Vascular and Interventional Neurology

AUGUST 4, 2024

This study analyzes the association between the hospital policy on local anesthesia (LA) versus general anesthesia, and the outcome of elective CEA in German hospitals.MethodsThis retrospective analysis is based on the nationwide German statutory carotid quality assurance database for the years 2012 to 2016.

Hospital 40

Hospital Outcomes Myocardial Infarction Stenosis 40

DAIC

JANUARY 3, 2024

Arbab-Zadeh, Heart Int 2012. HeartFlow is committed to serving customers quickly and reliably with a median turnaround time less than 1.5 4 In addition, HeartFlow accepts ~95% of all CCTAs submitted by customers for an FFR CT analysis. For more information: www.heartflow.com References 1. Yokota, et al. Neth Heart J 2018. Nakanishi, et al.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

Conquering CHD

DECEMBER 19, 2023

This month, Conquering CHD had the honor of engaging with the CDC directly, gaining valuable insights into their ongoing and future initiatives in CHD research and support. Our visit illuminated the extensive efforts and achievements of the CDC in this critical area of health.

Congenital 52

Congenital Quality of Life Public Health Education 52